Global Burden of Alcohol Use Disorders and Alcohol Liver Disease
Abstract
:1. Introduction
2. Materials and Methods
2.1. Definitions of Outcomes
2.2. Data Sources
3. Results
3.1. Alcohol Use Disorders
3.2. Alcoholic Liver Disease
4. Discussion
- The definition of AUDs, and its operationalization, are both controversial, as each is based on relatively unspecific criteria (e.g., [43]), is culture-specific, and can therefore not be easily compared [44,45]. They do not necessarily coincide perfectly with heavy drinking levels and can therefore not be linked to harm [11,12] or with biological research [7,13]. While alternatives do exist to estimate AUDs [46], these are not commonly used and we therefore did not use them.
- The reported deaths resulting from AUDs only include deaths where either AUDs or alcohol poisoning was listed as the cause of death on the death certificate (see above). Similar to other mental disorders, addictive disorders such as AUDs have been associated with considerable excess mortality [47,48,49,50], even though most of these disorders do not appear in large numbers in cause-of-death statistics. The underlying cause of death in the WHO Global Health Estimates [42] is defined as the disease or injury that initiated the train of morbid events which led directly to the death, or the circumstances of the accident or violence that produced the injury. For AUDs, the cause of death would therefore be attributed to injuries such as suicides, or other chronic disorders such as ischemic heart disease or ALD [1,50,51]. However, to avoid double counting, these deaths are not counted as AUDs mortality.
- The last limitation of the estimation of AUDs prevalence and harm in this study is the reliance on the Global Health Estimates, which do not provide confidence intervals [35]. There is obviously uncertainty inherent in the estimates of AUDs and attributable harm which we could not capture.
- The burden for ALD is clearly larger than for AUDs in terms of DALYs and particularly for mortality (but see previous point). ALD is the single most important health harm caused by alcohol use [4,5]. The estimation methodology used is consistent with the definition of ALD (i.e., without alcohol use, these cases of ALD deaths or disease would not have existed). However, in contrast to other causes of death, ALD deaths were not estimated based on death certificates (in the countries where such certificates exist), or based on specific verbal autopsies [52,53], but were indirectly estimated via attributable fractions (see Materials and Methods above). The reason for this is the high stigmatization of all disorders which have the terms ‘alcohol’ or ‘alcoholic’ in their names (for general considerations, see [54]). Alcohol’s involvement in a death may be missed by those certifying or reporting the death (the latter in verbal autopsies), or may be deliberately not mentioned to protect the reputation of the deceased (see [55], for further conclusions). A landmark study of death recording practices in 12 cities in 10 countries found that the number of deaths assigned to the ICD category ‘liver cirrhosis with mention of alcoholism’ rose by 135% after taking into account additional information obtained from hospital records and interviews with attending physicians and family members. The majority of the new cases were previously coded in categories like cirrhosis without any mention of alcohol [56]. Underestimation of ALD and other 100% alcohol-attributable disease categories has persisted to this day (e.g., [57]; see short overview of a recent study in [58]).
- Finally, while there was uncertainty reported around the ALD estimates, it may be underestimated as it did not include any uncertainty for the cause of death or burden of disease (i.e., only for exposure and risk relations) [59].
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Rehm, J.; Gmel Sr, G.E.; Gmel, G.; Hasan, O.S.; Imtiaz, S.; Popova, S.; Probst, C.; Roerecke, M.; Room, R.; Samokhvalov, A.V. The relationship between different dimensions of alcohol use and the burden of disease—An update. Addiction 2017, 112, 968–1001. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rehm, J.; Imtiaz, S. A narrative review of alcohol consumption as a risk factor for global burden of disease. Subst. Abus. Treat. Prev. Policy 2016, 11, 37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Murray, C.J.L. Quantifying the burden of disease: The technical basis for disability-adjusted life years. Bull. World Health Organ. 1994, 72, 429–445. [Google Scholar] [PubMed]
- World Health Organization. Global Status Report on Alcohol and Health 2018. Available online: https://www.who.int/substance_abuse/publications/global_alcohol_report/en/ (accessed on 28 October 2019).
- Shield, K.D.; Manthey, J.; Rylett, M.; Probst, C.; Wettlaufer, A.; Rehm, J. National, Regional, and Global Burdens of Disease from 2000 to 2016 Attributable to Alcohol Use. Lancet Public Health. (in press).
- Rehm, J.; Shield, K.D. Global Burden of Disease and the Impact of Mental and Addictive Disorders. Curr. Psychiatry Rep. 2019, 21, 10. [Google Scholar] [CrossRef]
- Carvalho, A.F.; Heilig, M.; Perez, A.; Probst, C.; Rehm, J. Alcohol use disorders. Lancet 2019, 394, 781–792. [Google Scholar] [CrossRef]
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Association: Philadelphia, PA, USA, 2013. [Google Scholar]
- World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. F10–F19 Mental and Behavioural Disorders due to Psychoactive Substance Use. Available online: https://www.who.int/substance_abuse/terminology/ICD10ClinicalDiagnosis.pdf (accessed on 27 November 2019).
- World Health Organization. ICD-11 for Mortality and Morbidity Statistics. Available online: https://icd.who.int/browse11/l-m/en (accessed on 27 November 2019).
- Rehm, J.; Marmet, S.; Anderson, P.; Gual, A.; Kraus, L.; Nutt, D.J.; Room, R.; Samokhvalov, A.V.; Scafato, E.; Trapencieris, M. Defining substance use disorders: Do we really need more than heavy use? Alcohol Alcohol. 2013, 48, 633–640. [Google Scholar] [CrossRef] [Green Version]
- Rehm, J.; Anderson, P.; Gual, A.; Kraus, L.; Marmet, S.; Nutt, D.J.; Room, R.; Samokhvalov, A.V.; Scafato, E.; Shield, K.D.; et al. The tangible common denominator of substance use disorders: A reply to commentaries to Rehm et al. (2013a). Alcohol Alcohol. 2014, 49, 118–122. [Google Scholar] [CrossRef] [Green Version]
- Rehm, J.; Heilig, M.; Gual, A. ICD-11 for Alcohol Use Disorders: Not a Convincing Answer to the Challenges. Alcohol. Clin. Exp. Res. 2019, 43. [Google Scholar] [CrossRef]
- Seitz, H.K.; Bataller, R.; Cortez-Pinto, H.; Gao, B.; Gual, A.; Lackner, C.; Mathurin, P.; Mueller, S.; Szabo, G.; Tsukamoto, H. Alcoholic liver disease. Nat. Rev. Dis. Primers 2018, 4, 16. [Google Scholar] [CrossRef]
- Rehm, J.; Samokhvalov, A.V.; Shield, K.D. Global burden of alcoholic liver diseases. J. Hepatol. 2013, 59, 160–168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- O’Shea, R.S.; Dasarathy, S.; McCullough, A.J.; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 2010, 51, 307–328. [Google Scholar] [CrossRef] [PubMed]
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J. Hepatol. 2018, 69, 154–181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- European Association for the Study of, L. EASL clinical practical guidelines: Management of alcoholic liver disease. J. Hepatol. 2012, 57, 399–420. [Google Scholar] [CrossRef]
- Teschke, R. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. Biomedicines 2018, 6, 106. [Google Scholar] [CrossRef] [Green Version]
- Teschke, R. Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance. Biomedicines 2019, 7, 68. [Google Scholar] [CrossRef] [Green Version]
- Teschke, R. Hepatocellular carcinoma in alcoholic liver disease: Mechanistic considerations and clinical facts. Hepatoma. Res. 2019, 5, 40. [Google Scholar] [CrossRef]
- Rehm, J.; Taylor, B.; Mohapatra, S.; Irving, H.; Baliunas, D.; Patra, J.; Roerecke, M. Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis. Drug Alcohol. Rev. 2010, 29, 437–445. [Google Scholar] [CrossRef]
- Roerecke, M.; Vafaei, A.; Hasan, O.S.M.; Chrystoja, B.R.; Cruz, M.; Lee, R.; Neuman, M.G.; Rehm, J. Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. Am. J. Gastroenterol. 2019, 114, 1574–1586. [Google Scholar] [CrossRef]
- Rehm, J.; Roerecke, M. Patterns of drinking and liver cirrhosis-what do we know and where do we go? J. Hepatol. 2015, 62, 1000–1001. [Google Scholar] [CrossRef] [Green Version]
- Marugame, T.; Yamamoto, S.; Yoshimi, I.; Sobue, T.; Inoue, M.; Tsugane, S.; Japan Public Health Center-based Prospective Study, G. Patterns of alcohol drinking and all-cause mortality: Results from a large-scale population-based cohort study in Japan. Am. J. Epidemiol. 2007, 165, 1039–1046. [Google Scholar] [CrossRef] [Green Version]
- Schwarzinger, M.; Thiebaut, S.P.; Baillot, S.; Mallet, V.; Rehm, J. Alcohol use disorders and associated chronic disease-a national retrospective cohort study from France. BMC Public Health 2017, 18, 43. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. ICD-10 Version: 2016. Available online: https://icd.who.int/browse10/2016/en (accessed on 28 October 2019).
- GBD 2017 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392, 1923–1994. [Google Scholar] [CrossRef] [Green Version]
- Institute of Health Metrics and Evaluation (GHDx). Global Burden of Disease Study 2015 (GBD 2015) Life Expectancy, All-Cause and Cause-Specific Mortality 1980–2015. Available online: http://ghdx.healthdata.org/record/ihme-data/gbd-2017-cause-icd-code-mappings (accessed on 28 October 2019).
- Murray, C.J.; Lopez, A.D. On the comparable quantification of health risks: Lessons from the Global Burden of Disease Study. Epidemiology 1999, 10, 594–605. [Google Scholar] [CrossRef] [Green Version]
- Rehm, J.; Monteiro, M.; Room, R.; Gmel, G.; Jernigan, D.; Frick, U.; Graham, K. Steps towards constructing a global comparative risk analysis for alcohol consumption: Determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur. Addict. Res. 2001, 7, 138–147. [Google Scholar] [CrossRef] [Green Version]
- Lopez, A.D.; Williams, T.N.; Levin, A.; Tonelli, M.; Singh, J.A.; Burney, P.G.; Rehm, J.; Volkow, N.D.; Koob, G.; Ferri, C.P. Remembering the forgotten non-communicable diseases. BMC Med. 2014, 12, 200. [Google Scholar] [CrossRef] [Green Version]
- Manthey, J.; Shield, K.D.; Rylett, M.; Hasan, O.S.M.; Probst, C.; Rehm, J. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: A modelling study. Lancet 2019, 393, 2493–2502. [Google Scholar] [CrossRef]
- Grant, B.F.; Chou, S.P.; Saha, T.D.; Pickering, R.P.; Kerridge, B.T.; Ruan, W.J.; Huang, B.; Jung, J.; Zhang, H.; Fan, A.; et al. Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 2017, 74, 911–923. [Google Scholar] [CrossRef]
- World Health Organization. Global Health Estimates (GHE). Available online: https://www.who.int/healthinfo/global_burden_disease/en/ (accessed on 28 October 2019).
- Rehm, J.; Shield, K.D.; Frick, U. Epidemiologie alkoholischer Lebererkrankungen. In Alkoholische Leber- und Krebserkrankungen; Seitz, S.M.H.K., Ed.; De Gruyter.: Berlin, Germany, 2019; pp. 25–40. [Google Scholar]
- World Health Organization. Fact Sheet: Hepatitis B. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (accessed on 28 October 2019).
- Messina, J.P.; Humphreys, I.; Flaxman, A.; Brown, A.; Cooke, G.S.; Pybus, O.G.; Barnes, E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015, 61, 77–87. [Google Scholar] [CrossRef] [Green Version]
- Schwarzinger, M.; Baillot, S.; Yazdanpanah, Y.; Rehm, J.; Mallet, V. Alcohol use disorders and the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study. J. Hepatol. 2017, 67, 454–461. [Google Scholar] [CrossRef] [Green Version]
- Alavi, M.; Janjua, N.Z.; Chong, M.; Grebely, J.; Aspinall, E.J.; Innes, H.; Valerio, H.M.; Hajarizadeh, B.; Hayes, P.C.; Krajden, M.; et al. The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study. J. Hepatol. 2018, 68, 393–401. [Google Scholar] [CrossRef] [Green Version]
- Schwarzinger, M.; Rehm, J.; Mallet, V. “Who killed JR”: Chronic hepatitis C or alcohol use disorders? J. Hepatol. 2018, 68, 1098–1099. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. Disease Burden and Mortality Estimates: Cause-Specific Mortality. 2000–2016. Available online: http://www.who.int/healthinfo/global_burden_disease/estimates/en/ (accessed on 28 October 2019).
- Martin, C.S.; Langenbucher, J.W.; Chung, T.; Sher, K.J. Truth or consequences in the diagnosis of substance use disorders. Addiction 2014, 109, 1773–1778. [Google Scholar] [CrossRef] [Green Version]
- Rehm, J.; Room, R. Cultural specificity in alcohol use disorders. Lancet 2015. [Google Scholar] [CrossRef]
- Rehm, J.; Room, R. The cultural aspect: How to measure and interpret epidemiological data on alcohol-use disorders across cultures. Nord. Stud. Alcohol Drugs 2017, 34, 330–341. [Google Scholar] [CrossRef]
- Rehm, J. How should prevalence of alcohol use disorders be assessed globally? Int. J. Methods Psychiatr. Res. 2016, 25, 79–85. [Google Scholar] [CrossRef]
- Charlson, F.J.; Baxter, A.J.; Dua, T.; Degenhardt, L.; Whiteford, H.A.; Vos, T. Excess Mortality from Mental, Neurological, and Substance Use Disorders in the Global Burden of Disease Study 2010. In Mental, Neurological, and Substance Use Disorders, Disease Control Priorities; Patel, V., Dua, T., Laxminarayan, R., Medina-Mora, M.E., Eds.; The International Bank for Reconstruction and Development/The World Bank: Washington, DC, USA, 2016; Volume 4, pp. 41–65. [Google Scholar]
- Rehm, J.; Dawson, D.; Frick, U.; Gmel, G.; Roerecke, M.; Shield, K.D.; Grant, B. Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin. Exp. Res. 2014, 38, 1068–1077. [Google Scholar] [CrossRef]
- Roerecke, M.; Rehm, J. Alcohol use disorders and mortality: A systematic review and meta-analysis. Addiction 2013, 108, 1562–1578. [Google Scholar] [CrossRef]
- Harris, E.C.; Barraclough, B. Excess mortality of mental disorder. Br. J. Psychiatry 1998, 173, 11–53. [Google Scholar] [CrossRef]
- Roerecke, M.; Rehm, J. Cause-specific mortality risk in alcohol use disorder treatment patients: A systematic review and meta-analysis. Int. J. Epidemiol. 2014, 43, 906–919. [Google Scholar] [CrossRef]
- Soleman, N.; Chandramohan, D.; Shibuya, K. Verbal autopsy: Current practices and challenges. Bull. World Health Organ. 2006, 84, 239–245. [Google Scholar] [CrossRef]
- Thomas, L.M.; D’Ambruoso, L.; Balabanova, D. Verbal autopsy in health policy and systems: A literature review. BMJ Glob. Health 2018, 3, e000639. [Google Scholar] [CrossRef] [Green Version]
- Schomerus, G.; Lucht, M.; Holzinger, A.; Matschinger, H.; Carta, M.G.; Angermeyer, M.C. The stigma of alcohol dependence compared with other mental disorders: A review of population studies. Alcohol Alcohol. 2011, 46, 105–112. [Google Scholar] [CrossRef] [Green Version]
- Lange, S.; Roerecke, M.; Rehm, J. For most fully alcohol-attributable diagnoses in the ICD, the etiological specification should be removed. Adicciones. (in press).
- Puffer, R.R.; Griffith, G.W. Patterns of Urban Mortality: Report of the Inter-American Investigation of Mortality; Pan American Health Organization: Washington, DC, USA, 1967. [Google Scholar]
- Tuusov, J.; Lang, K.; Vali, M.; Parna, K.; Tonisson, M.; Ringmets, I.; McKee, M.; Helander, A.; Leon, D.A. Prevalence of alcohol-related pathologies at autopsy: Estonian Forensic Study of Alcohol and Premature Death. Addiction 2014, 109, 2018–2026. [Google Scholar] [CrossRef]
- Rehm, J.; Hasan, O.S.M.; Imtiaz, S.; Neufeld, M. Quantifying the contribution of alcohol to cardiomyopathy: A systematic review. Alcohol 2017, 61, 9–15. [Google Scholar] [CrossRef]
- Gmel, G.; Shield, K.D.; Frick, H.; Kehoe, T.; Gmel, G.; Rehm, J. Estimating uncertainty of alcohol-attributable fractions for infectious and chronic diseases. BMC Med. Res. Methodol 2011, 11, 48. [Google Scholar] [CrossRef] [Green Version]
- Case, A.; Deaton, A. Mortality and morbidity in the 21(st) century. Brook. Pap. Econ. Act. 2017, 2017, 397–476. [Google Scholar] [CrossRef] [Green Version]
- Rehm, J.; Probst, C. Decreases of Life Expectancy Despite Decreases in Non-Communicable Disease Mortality: The Role of Substance Use and Socioeconomic Status. Eur. Addict. Res. 2018, 24, 53–59. [Google Scholar] [CrossRef]
- Woolf, S.H.; Schoomaker, H. Life Expectancy and Mortality Rates in the United States, 1959-2017. JAMA 2019, 322, 1996–2016. [Google Scholar] [CrossRef]
- Statistics Canada. The Daily: Changes in Life Expectancy by Selected Causes of Death. 2017. Available online: https://www150.statcan.gc.ca/n1/en/daily-quotidien/190530/dq190530d-eng.pdf?st=21plbOYt (accessed on 29 October 2019).
- Probst, C.; Rehm, J. Alcohol use, opioid overdose and socioeconomic status in Canada: A threat to life expectancy? CMAJ 2018, 190, E1294–E1295. [Google Scholar] [CrossRef] [Green Version]
- Tjepkema, M.; Wilkins, R.; Long, A. Cause-specific mortality by income adequacy in Canada: A 16-year follow-up study. Health Rep. 2013, 24, 14–22. [Google Scholar]
- Alcohol Harm in Canada: Examining Hospitalizations Entirely Caused by Alcohol and Strategies to Reduce Alcohol Harm. Available online: https://secure.cihi.ca/estore/productFamily.htm?pf=PFC3445&lang=fr&media= (accessed on 22 June 2017).
- Babor, T.F.; Caetano, R.; Casswell, S.; Edwards, G.; Giesbrecht, N.; Graham, K.; Grube, J.; Gruenewald, P.; Hill, L.; Holder, H.; et al. Alcohol: No Ordinary Commodity. Research and Public Policy, 2nd ed.; Oxford University Press: London, UK, 2010. [Google Scholar]
- Chisholm, D.; Moro, D.; Bertram, M.; Pretorius, C.; Gmel, G.; Shield, K.; Rehm, J. Are the “Best Buys” for Alcohol Control Still Valid? An Update on the Comparative Cost-Effectiveness of Alcohol Control Strategies at the Global Level. J. Stud. Alcohol Drugs 2018, 79, 514–522. [Google Scholar] [CrossRef] [PubMed]
- Anderson, P.; Chisholm, D.; Fuhr, D.C. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009, 373, 2234–2246. [Google Scholar] [CrossRef]
- O’Donnell, A.; Anderson, P.; Jane-Llopis, E.; Manthey, J.; Kaner, E.; Rehm, J. Immediate impact of minimum unit pricing on alcohol purchases in Scotland: Controlled interrupted time series analysis for 2015-18. BMJ 2019, 366, l5274. [Google Scholar] [CrossRef] [PubMed] [Green Version]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rehm, J.; Shield, K.D. Global Burden of Alcohol Use Disorders and Alcohol Liver Disease. Biomedicines 2019, 7, 99. https://doi.org/10.3390/biomedicines7040099
Rehm J, Shield KD. Global Burden of Alcohol Use Disorders and Alcohol Liver Disease. Biomedicines. 2019; 7(4):99. https://doi.org/10.3390/biomedicines7040099
Chicago/Turabian StyleRehm, Jürgen, and Kevin D. Shield. 2019. "Global Burden of Alcohol Use Disorders and Alcohol Liver Disease" Biomedicines 7, no. 4: 99. https://doi.org/10.3390/biomedicines7040099
APA StyleRehm, J., & Shield, K. D. (2019). Global Burden of Alcohol Use Disorders and Alcohol Liver Disease. Biomedicines, 7(4), 99. https://doi.org/10.3390/biomedicines7040099